Readily raised $11 million in a Series A round to support its compliance intelligence platform, aimed at helping life sciences organizations manage regulatory and operational requirements. The round was led by Define Ventures, with participation from Y Combinator and the California Health Care Foundation Innovation Fund. The funding highlights continued investor focus on enterprise software that reduces compliance friction in drug development and healthcare operations. For biopharma teams, such platforms can affect audit readiness, policy workflows, and operational risk management. In practical terms, the new capital suggests Readily will expand product coverage and customer deployments at a time when healthcare data governance and documentation expectations remain under pressure.